Free Communication Clinical Orals #3: Novel Intervention Therapies in Type 1 Diabetes
Tracks
Breakout 3: Central B&C
Wednesday, August 20, 2025 |
2:30 PM - 3:30 PM |
Central Room B&C |
Speaker
Dr Jennifer Snaith
Endocrinologist
Garvan Institute of Medical Research
Tirzepatide in adults with type 1 diabetes: a phase 2 randomised controlled clinical trial
2:30 PM - 2:45 PMBiography
Dr Jennifer Snaith is an Endocrinologist and post-doctoral researcher. She leads the young adult diabetes service at St Vincent’s Hospital, Sydney. Her research interest is the intersection between type 1 diabetes, metabolic and cardiovascular health. She was awarded the UNSW Dean’s Award for her PhD, a study of the effect of metformin on muscle and liver insulin resistance in T1D. She conducts adjunctive therapies clinical trials in T1D, including INTIMET study (metformin), RESET1 (semaglutide) and TIRTLE (tirzepatide). Jen’s post-doctoral work is a supported by Breakthrough T1D Australia (Rebecca Davies Fellowship).
Dr Luke Ephraums
Endocrine Advanced Trainee
SA Health
Dr Dale Morrison
Research Fellow
University of Melbourne
Whey protein intervention to mitigate hypoglycaemia risk in people with type 1 diabetes
3:00 PM - 3:15 PMBiography
Dr Morrison is an exercise physiologist and senior research fellow at the University of Melbourne, focussing on the interface of type 1 diabetes, technology and exercise. Dr Morrison's other research interests include glucose metabolism, muscle physiology and nutrition.
Mr Lucas Agnoletto
Research Assistant
University of Melbourne
Pre-exercise whey protein ingestion to mitigate exercise-induced hypoglycemia in adults with type 1 diabetes.
3:15 PM - 3:30 PMBiography
Lucas is a research assistant working with the Diabetes Technology Research Group based at St Vincent's Hospital, Melbourne. He is a medical student who is interested in metabolism and endocrinology.
Prof Jerry Greenfield
Head of Department / Endocrinology and Diabetes
St Vincent's Health Network Sydney
Chairperson
Biography
Dr Barbora Paldus
Endocrinologist
University of Melbourne
Chairperson
Biography
Dr Barb Paldus is an Endocrinologist and Senior Clinical Research Fellow with the University of Melbourne and St Vincent’s Hospital Diabetes Technology Research Group. Barb has special clinical and research interests in the application of diabetes technologies to the management of type 1 diabetes particularly during exercise. Beyond her consultancy roles at several Victorian public hospitals she has completed a PhD at the University of Melbourne, focusing on advancing automated insulin delivery and other innovative technologies for optimal type 1 diabetes management during exercise. With numerous publications in diabetes technology, Barb has earned multiple scholarships and awards in this domain and presented both nationally and internationally.
